← Back to Patent Explorer
US5215680A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles

Assignee: Cavitation-Control Technology Inc
•
Filing: 1990-07-10
•
Granted: 1993-06-01
•
Expires: 2010-07-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to a large scale method for the production of medical grade lipid-coated microbubbles, to the paramagnetic labeling of such microbubbles and to therapeutic applications for the microbubbles. More particularly, the invention relates to a method of the production of medical grade, concentrated suspensions of stable, paramagnetically derivatized or underivatized microbubbles useful for ultrasonic and magnetic resonance imaging and also relates to therapeutic interventions such as selective tumor destruction.

Inventors

  • 👤 Joseph S. D'Arrigo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:56
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5015; A61K41/00; A61K41/0047; A61K49/00; A61K49/06; A61K49/18; A61K49/1806; A61K49/1815; A61K49/22; A61K49/222; A61K49/223; Y; Y10; Y10T; Y10T436/00; Y10T436/24

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 292 words
A method for preparing an imaging about suitable for enhancement of ultrasonic imaging and magnetic resonance imaging comprising the steps of: A. obtaining a moderately hydrophobic neutral amino acid homopolymer or copolymer which is capable of readily incorporating into a lipid monolayer, and is labeled with a paramagnetic complex comprising a metal ion and organic chelating ligand; B. dissolving the labeled, hydrophobic polymer in a saline solution in an amount of about 10 mM; C. adding a surfactant mixture comprising: (a) a member selected from the group consisting of glycerol monoesters of saturated carboxylic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; (b) a sterol-aromatic acid ester; (c) a member selected from the group consisting of sterols, terpenes, bile acids and alkali metal salts of bile acids; (d) a member selected from the group consisting of sterol esters of aliphatic acids containing from one to about 18 carbon atoms; sterol esters of sugar acids; esters of sugar acids and aliphatic alcohols containing from about 10 to about 18 carbon atoms, esters of sugars and aliphatic acids containing from about 10 to about 18 carbon atoms; sugar acids, saponins; and sapogenins; and (e) a member selected from the group consisting of glycerol, glycerol di or triesters of aliphatic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; D. shaking said solution mechanically for from about 2 to about 10 seconds in gaseous atmosphere at room temperature, thereby forming a concentrated gas-in-liquid emulsion; and E. passing the solution obtained after step (D) through a sterile polysulfone membrane filter having an average pore diameter of about 0.40-6.0 μm.
Claim 2
Independent Claim 292 words
A method for preparing an imaging about suitable for enhancement of ultrasonic imaging and magnetic resonance imaging comprising the steps of: A. obtaining a moderately hydrophobic neutral amino acid homopolymer or copolymer which is capable of readily incorporating into a lipid monolayer, and is labeled with a paramagnetic complex comprising a metal ion and organic chelating ligand; B. dissolving the labeled, hydrophobic polymer in a saline solution in an amount of about 10 mM; C. adding a surfactant mixture comprising: (a) a member selected from the group consisting of glycerol monoesters of saturated carboxylic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; (b) a sterol-aromatic acid ester; (c) a member selected from the group consisting of sterols, terpenes, bile acids and alkali metal salts of bile acids; (d) a member selected from the group consisting of sterol esters of aliphatic acids containing from one to about 18 carbon atoms; sterol esters of sugar acids; esters of sugar acids and aliphatic alcohols containing from about 10 to about 18 carbon atoms, esters of sugars and aliphatic acids containing from about 10 to about 18 carbon atoms; sugar acids, saponins; and sapogenins; and (e) a member selected from the group consisting of glycerol, glycerol di or triesters of aliphatic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; D. shaking said solution mechanically for from about 2 to about 10 seconds in gaseous atmosphere at room temperature, thereby forming a concentrated gas-in-liquid emulsion; and E. passing the solution obtained after step (D) through a sterile polysulfone membrane filter having an average pore diameter of about 0.40-6.0 μm.
Claim 3
Dependent Claim 34 words
A method according to claim 1, further comprising the steps of allowing undissolved lipid materials to settle out for a period of about 15-60 minutes before passing the solution through the polysulfone membrane filter.
Claim 4
Dependent Claim 21 words
A method according to claim 2, wherein the sterile polysulfone membrane filter has an average pore diameter of about 0.40-0.60 μm.
Claim 5
Dependent Claim 21 words
A method according to claim 3, wherein the sterile polysulfone membrane filter has an average pore diameter of about 45 μm.
Claim 6
Dependent Claim 27 words
A method according to claim 3, wherein the moderately hydrophobic polymer is selected from the group consisting of homopolymers of valine, glycine and alanine and copolymers thereof.
Claim 7
Dependent Claim 26 words
A method according to claim 5, wherein the paramagnetic complex is selected from the group consisting of gadolinium DTPA, manganese DTPA, gadolinium EDTA and manganese EDTA.
Claim 8
Dependent Claim 13 words
A method according to claim 6 wherein the paramagnetic complex is gadolinium DTPA.
Claim 9
Dependent Claim 25 words
A method according to claim 7, wherein the surfactant mixture components are present in the surfactant mixture in a weight ratio a:b:c:d:e of about 2-4:0.5-1.5:0.5-1.5:0.5-1.5:0-1.5.
Claim 10
Dependent Claim 29 words
A method according to claim 8, wherein the surfactant mixture consists essentially of glycerol monolaurate, cholesterol benzoate, cholesterol, cholesterol acetate and glycerol tripalmitate in a weight ratio of 2-4:1:1:1:1.
Claim 11
Dependent Claim 29 words
A method according to claim 1, further comprising the steps of mechanically shaking the solution at least two more times before passing the solution through the polysulfone membrane filter.

References Cited (Backward Citations)

US4276885A Cited
US4466442A Cited
US4572203A Cited
US4900540A Cited
US4985233A Cited
US4684479A Cited
US4832941A Cited
US4774958A Cited
US4927637A Cited
US5078986A Cited
US5088499A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-05-31 1996-11-30 1997-06-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-05-31 2000-11-30 2001-06-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-05-31 2004-11-30 2005-06-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag